Enterprise Value
2.533M
Cash
3.10M
Avg Qtr Burn
-5.118M
Short % of Float
0.71%
Insider Ownership
0.00%
Institutional Own.
0.00%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ZIMHI (naloxone 5mg) Details Opioid Overdose | Approved Quarterly sales | |
SYMJEPI (epinephrine 0.3mg and 0.15mg) Details Anaphylaxis | Approved Quarterly sales | |
APC-410 (tempol) Details Acute respiratory distress syndrome, Inflammatory disease, COVID-19 | Failed Discontinued | |
APC-400 (tempol) Details Radiation Dermatitis | Failed Discontinued |